MECHANISM OF ACTION:Myosoft binds to GABA-A and strychnine sensitive glycine receptors. Mysoft acting as a GABA-A receptor anatagonist, its myorelaxant effects could be exerted at the supra spinal level via complex regulatory mechanisms. Although a glycinergic mechanism of action cannot be excluded.
INDICATIONS:Treatment of the painful muscular contractures in acute and chronic rhemumatologic and orthopedic diseases (lumbago, Sciatica, Cervicobrachial pain, torticollis, periarthropathy, tendinopathy)or in traumatology.
DOSAGE AND ADMINISTRATION:Two 4mg Capsules BID for 5-7 days.
PRESENTATION:Myosoft Capsules are available in the pack size of 4×5’s ALU ALU Blister pack.